Actively Recruiting
Study of Clareon TruPlus Monofocal Intraocular Lenses for Cataract Surgery Patients Evaluating Safety and Vision Outcomes After Lens Implantation
Led by Alcon Research · Updated on 2026-10-30
185
Participants Needed
5
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research study focuses on evaluating the safety and performance of Clareon TruPlus Monofocal Intraocular Lenses IOLs, which are implanted during cataract surgery to restore clear vision after the cloudy natural lens is removed. The lenses are intended to stay in the eyes for the patients lifetime. The study targets adults diagnosed with aphakia and astigmatism who are undergoing cataract surgery. Participants will receive Clareon TruPlus Monofocal IOLs, either Non-Toric or Toric, implanted using a phacoemulsification procedure. The choice of lens type depends on the individuals astigmatism and surgeon recommendation. The study includes one preoperative visit, two surgical visitsincluding second eye surgery within 0 to 14 days after the firstand five postoperative visits over approximately 13 months. During the trial, participants will be monitored through eight study visits with assessments including vision quality checks using the Mean Binocular Photopic Best Corrected Distance Visual Acuity at baseline and at 1, 3, and 12 months after surgery. The study tracks how well the lenses perform and their safety over time, supporting long-term observation after lens implantation.
CONDITIONS
Brief Title
Clareon TruPlus Study
Research Team
A
Alcon Call Center
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here